Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Landos Biopharma (LABP) Q1 2024 Earnings
LABP
9
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.43
-1.16
-0.9
-0.63
Details
Expected EPS
-1
Actual EPS
-1.43
Surprise EPS
-0.43
Surprise Percent
+43%
Description
Landos Biopharma (LABP) has reported earnings of -1.43 per share for Q1 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login